| NCT05727878 | Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-02-07 | 2026-06 | 2025-09 |
| NCT03616899 | Safety and Efficacy of KPI-121 in Subjects With DED | COMPLETED | PHASE3 | 2018-07-10 | 2020-02-05 | 2020-02-05 |
| NCT03596723 | KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children | TERMINATED | PHASE3 | 2018-07-03 | 2018-10-18 | 2018-09-28 |
| NCT02813265 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2016-06 | 2017-10 | 2017-10 |
| NCT02819284 | Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2016-06 | 2017-09 | 2017-09 |
| NCT02793817 | Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain | COMPLETED | PHASE3 | 2016-06 | 2017-03 | 2017-03 |
| NCT02218489 | Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease | COMPLETED | PHASE2 | 2014-07 | 2016-06 | 2015-12 |
| NCT02245516 | Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema | COMPLETED | NA | 2014-07 | 2014-12 | 2014-12 |
| NCT02188160 | Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease | COMPLETED | PHASE2 | 2014-06 | 2015-03 | 2015-01 |
| NCT02163824 | Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation | COMPLETED | PHASE3 | 2014-05 | 2014-12 | 2014-12 |